Synopsis: The syrup, marketed under the name Coldrif, had been distributed to Rajasthan, Madhya Pradesh, and Puducherry. Following the alarming reports of child fatalities due to suspected kidney failure, the Tamil Nadu government imposed a statewide ban on the sale of Coldrif, effective 1 October.

Authorities in Tamil Nadu have halted the production of a Chennai-based pharmaceutical firm after test results confirmed adulteration in samples of its cough syrup.

The action comes amid growing concerns over the deaths of several children in Madhya Pradesh and Rajasthan, allegedly linked to the consumption of the syrup.

Officials from the Food Safety and Drug Administration inspected the company’s manufacturing facility in Sunguvarchathram, Kancheepuram district, and collected samples that

See Full Page